Source:http://linkedlifedata.com/resource/pubmed/id/11679204
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-10-26
|
pubmed:abstractText |
The present study was designed to determine whether nitric oxide (NO)-induced reduction of [Ca(2+)](i) is associated with Ca(2+)-induced Ca(2+) release (CICR) in coronary arterial smooth muscle cells (CASMCs). Caffeine was used as a CICR activator to induce Ca(2+) release in these cells. The effects of NO donor, sodium nitroprusside (SNP), on caffeine-induced Ca(2+) release were examined in freshly dissociated bovine CASMCs using single cell fluorescence microscopic spectrometry. The effects of NO donor on caffeine-induced coronary vasoconstriction were examined by isometric tension recordings. Caffeine, a CICR or ryanodine receptor (RYR) activator, produced a rapid Ca(2+) release with a 330 nM increase in [Ca(2+)](i). Pretreatment of the CASMCs with SNP, CICR inhibitor tetracaine or RYR blocker ryanodine markedly decreased caffeine-induced Ca(2+) release. Addition of caffeine to the Ca(2+)-free bath solution produced a transient coronary vasoconstriction. SNP, tetracaine and ryanodine, but not guanylyl cyclase inhibitor, ODQ, significantly attenuated caffeine-induced vasoconstriction. These results suggest that CICR is functioning in CASMCs and participates in the vasoconstriction in response to caffeine-induced Ca(2+) release and that inhibition of CICR is of importance in mediating the vasodilator response of coronary arteries to NO.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Caffeine,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroprusside,
http://linkedlifedata.com/resource/pubmed/chemical/Oxyhemoglobins,
http://linkedlifedata.com/resource/pubmed/chemical/Ryanodine,
http://linkedlifedata.com/resource/pubmed/chemical/Tetracaine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0306-3623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37-45
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11679204-Animals,
pubmed-meshheading:11679204-Arteries,
pubmed-meshheading:11679204-Caffeine,
pubmed-meshheading:11679204-Calcium,
pubmed-meshheading:11679204-Cattle,
pubmed-meshheading:11679204-Coronary Vessels,
pubmed-meshheading:11679204-Models, Cardiovascular,
pubmed-meshheading:11679204-Muscle, Smooth, Vascular,
pubmed-meshheading:11679204-Nitric Oxide,
pubmed-meshheading:11679204-Nitroprusside,
pubmed-meshheading:11679204-Oxyhemoglobins,
pubmed-meshheading:11679204-Ryanodine,
pubmed-meshheading:11679204-Tetracaine,
pubmed-meshheading:11679204-Vasoconstriction
|
pubmed:year |
2000
|
pubmed:articleTitle |
Effect of nitric oxide on calcium-induced calcium release in coronary arterial smooth muscle.
|
pubmed:affiliation |
Department of Pharmacology and Toxicology, Medical College of Wisconsin, 53226, Milwaukee, WI, USA
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|